(ARQT)
Now that Arcutis Biotherapeutics Inc’s volume has hit 2.59 million, investors get a glimpse of its size.
On Friday, Arcutis Biotherapeutics Inc (NASDAQ: ARQT) was 7.90% up from the session before settling in for the closing price ...
$2.08M in average volume shows that Arcutis Biotherapeutics Inc (ARQT) is heading in the right direction
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) on Friday, soared 9.36% from the previous trading day, before settling in for the closing ...
A Little Luck Can Go a Long Way with Arcutis Biotherapeutics Inc (ARQT) as it 5-day change was 0.72%
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) started the day on Thursday, with a price increase of 2.95% at $25.1, before settling ...
71.12% percent quarterly performance for Arcutis Biotherapeutics Inc (ARQT) is not indicative of the underlying story
On Tuesday, Arcutis Biotherapeutics Inc (NASDAQ: ARQT) opened higher 27.04% from the last session, before settling in for the closing ...
Arcutis Biotherapeutics Inc (ARQT) is expecting 48.77% growth in the next quarter: What can investors do to maximize their returns?
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) kicked off on Friday, down -6.26% from the previous trading day, before settling in for ...
Arcutis Biotherapeutics Inc (ARQT) EPS is poised to hit -0.09 next quarter: How Investors Can Make It Count the Most?
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) started the day on Wednesday, with a price increase of 4.83% at $19.76, before settling ...
